Abacavir, dolutegravir, and lamivudine and Tafenoquine (Malaria Prevention)
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Tafenoquine (Malaria Prevention) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Tafenoquine (Prevention of Malaria Relapse)
- Abacavir, dolutegravir, and lamivudine-Tafenoquine Succinate (Arakoda)
- Abacavir, dolutegravir, and lamivudine-Tafenoquine Succinate (Krintafel)
- Abacavir, dolutegravir, and lamivudine-Tafinlar
- Abacavir, dolutegravir, and lamivudine-Tafluprost
- Abacavir, dolutegravir, and lamivudine-Tafluprost ophthalmic
- Tafenoquine (Malaria Prevention)-Abacavir, Lamivudine and Zidovudine Tablets
- Tafenoquine (Malaria Prevention)-Abacavir, lamivudine, and zidovudine
- Tafenoquine (Malaria Prevention)-Abaloparatide
- Tafenoquine (Malaria Prevention)-Abaloparatide Subcutaneous
- Tafenoquine (Malaria Prevention)-Abatacept
- Tafenoquine (Malaria Prevention)-Abatacept Auto-Injectors